# Algal DHA (Schizochytrium sp.)

**Canonical URL:** https://ingredients.hermeticasuperfoods.com/ingredients/algal-dha
**Data Source:** Hermetica Superfoods Ingredient Encyclopedia
**Updated:** 2026-04-04
**Evidence Score:** 2 / 10
**Category:** Other
**Also Known As:** Schizochytrium DHA, Microalgal DHA, Fermented algae DHA, Marine algae DHA, Algae-derived docosahexaenoic acid, Schizochytrium oil, Algal omega-3 DHA, Plant-based DHA, Vegan DHA, Single-cell oil DHA

## Overview

Algal DHA derived from Schizochytrium sp. is a microalgae-sourced docosahexaenoic acid (DHA) that serves as a vegan alternative to fish oil omega-3s. It provides the same 22-carbon, 6-double-bond fatty acid that supports neurological function and cell membrane integrity without relying on marine animal sources.

## Health Benefits

• No clinical health benefits documented - research focuses only on production methods
• No human trials available in the provided research
• No meta-analyses or RCTs found in the research dossier
• No evidence for specific health outcomes provided
• Production research shows high DHA yield but no health applications studied

## Mechanism of Action

DHA incorporates into phospholipid bilayers of neuronal and retinal cell membranes, modulating membrane fluidity and the function of G-protein-coupled receptors involved in signal transduction. It acts as a precursor to specialized pro-resolving mediators (SPMs) such as neuroprotectins and resolvins via 15-lipoxygenase and cytochrome P450 enzymatic pathways, which help regulate inflammatory responses. DHA also downregulates NF-κB signaling and reduces transcription of [pro-inflammatory cytokine](/ingredients/condition/inflammation)s including TNF-α and IL-6.

## Clinical Summary

Human clinical evidence specifically for Schizochytrium sp.-derived algal DHA is extremely limited in the published literature, with available research concentrated heavily on fermentation optimization and lipid extraction methods rather than therapeutic outcomes. Bioavailability studies suggest algal DHA achieves equivalent plasma DHA enrichment compared to fish oil DHA, as demonstrated in small crossover trials, but large-scale RCTs isolating this specific algal strain are absent. The broader DHA literature—largely derived from fish oil and mixed EPA/DHA supplement trials—shows modest [cardiovascular](/ingredients/condition/heart-health) and [cognitive](/ingredients/condition/cognitive) benefits, but these findings cannot be directly attributed to Schizochytrium sp. algal DHA without dedicated human trials. Overall evidence strength for this specific ingredient is low, and health claims must be extrapolated cautiously from the general DHA literature.

## Nutritional Profile

Algal DHA from Schizochytrium sp. is a highly concentrated source of the omega-3 long-chain polyunsaturated fatty acid docosahexaenoic acid (DHA, 22:6n-3), typically comprising 35–50% of total fatty acids in the extracted oil, with some optimized strains yielding up to 50–70% DHA of total lipid content. Total lipid content of the biomass ranges from 50–77% dry weight under optimized fermentation conditions. The oil also contains docosapentaenoic acid (DPA, 22:5n-6) as a notable co-occurring fatty acid, typically at 10–25% of total fatty acids, which distinguishes it from fish-derived DHA oils. Saturated fatty acids, primarily palmitic acid (C16:0), constitute approximately 20–40% of total fatty acids. EPA (20:5n-3) is present in only trace or negligible amounts, unlike fish oil. The oil contains no protein, no dietary fiber, and negligible carbohydrates. Micronutrient content includes naturally occurring tocopherols (vitamin E compounds) at low levels, which serve as [antioxidant](/ingredients/condition/antioxidant)s within the oil matrix. Astaxanthin and other carotenoids may be present in minor quantities depending on processing. The DHA is delivered in triglyceride form, which has established bioavailability comparable to fish oil triglycerides, with absorption efficiency estimated at 95% or greater in the presence of dietary fat. The product is free of fishy contaminants, heavy metals (when properly refined), and environmental pollutants such as PCBs and dioxins that can be present in marine-sourced DHA, making bioavailability less subject to interference from contaminant binding.

## Dosage & Preparation

No clinically studied dosage ranges are available in the research. Production studies report fermentation yields of 26-30 g/L DHA in broth and extraction yields of 51% DHA in oil, but human dosing has not been established. Consult a healthcare provider before starting any new supplement.

## Safety & Drug Interactions

Algal DHA from Schizochytrium sp. is generally recognized as safe (GRAS) by the FDA and is approved as an ingredient in infant formula, with no serious adverse events reported at typical supplemental doses of 200–500 mg/day. At higher doses exceeding 2–3 g/day, DHA may exert mild anticoagulant effects by reducing platelet aggregation via thromboxane A2 inhibition, warranting caution in individuals taking anticoagulants such as warfarin or antiplatelet drugs like clopidogrel. Algal DHA is considered safe during pregnancy and lactation and is commonly recommended for fetal neurodevelopment at 200 mg/day, making it a preferred fish-free option for pregnant individuals concerned about marine contaminants. Individuals with algae hypersensitivity should exercise caution, and those with fish or shellfish allergies should confirm cross-reactivity risk with their healthcare provider, though such reactions are rare.

## Scientific Research

The provided research contains no human clinical trials, RCTs, or meta-analyses on algal DHA from Schizochytrium sp. All available studies focus exclusively on fermentation, extraction, and purification processes rather than health outcomes or clinical applications.

## Historical & Cultural Context

Schizochytrium sp. has no traditional medicine history, as it is a modern biotechnology development. This microalgae source was developed specifically to provide a sustainable alternative to fish oil through fermentation technology.

## Synergistic Combinations

EPA, Vitamin E, Astaxanthin, Phospholipids, CoQ10

## Frequently Asked Questions

### Is algal DHA from Schizochytrium sp. as effective as fish oil DHA?

Small crossover bioavailability studies indicate that DHA from Schizochytrium sp. microalgae raises plasma and red blood cell DHA levels comparably to fish oil-derived DHA, since both deliver the identical 22:6n-3 fatty acid molecule. Fish ultimately obtain their DHA by consuming microalgae like Schizochytrium sp., so algal DHA is essentially the original dietary source. However, head-to-head large RCTs comparing clinical outcomes between the two forms are lacking.

### What is the recommended dosage of algal DHA supplement?

General health organizations such as WHO and EFSA recommend 200–500 mg of DHA per day for healthy adults to maintain baseline omega-3 status. Pregnant and breastfeeding individuals are commonly advised to take at least 200 mg of DHA daily specifically for fetal and infant brain development. Therapeutic doses used in cardiovascular and cognitive research typically range from 1,000–2,000 mg DHA/day, but these are not specifically established for Schizochytrium sp. algal DHA alone.

### Is algal DHA safe for vegans and vegetarians?

Yes, Schizochytrium sp. is a heterotrophic microalgae fermented in controlled bioreactor conditions without any animal-derived inputs, making its DHA fully vegan and vegetarian. It is the primary commercially available direct source of long-chain omega-3 DHA that does not involve fish, krill, or other marine animals. This makes it the recommended DHA source for plant-based individuals who cannot obtain adequate DHA through ALA conversion from flaxseed or chia, as ALA-to-DHA conversion efficiency in humans is below 5%.

### Can algal DHA interact with blood thinning medications?

At supplemental doses above 2–3 g of DHA per day, omega-3 fatty acids including algal DHA can inhibit platelet aggregation by reducing thromboxane A2 synthesis, which may potentiate the effects of anticoagulants like warfarin or antiplatelet agents such as aspirin and clopidogrel. This interaction is generally considered low-risk at standard doses of 200–500 mg/day but should be disclosed to a prescribing physician before combining with blood-thinning therapy. INR monitoring may be advisable for warfarin users who initiate high-dose DHA supplementation.

### Why is algal DHA used in infant formula instead of fish oil?

Schizochytrium sp.-derived algal DHA is used in infant formula because it delivers a purified, contaminant-free source of DHA free from mercury, PCBs, and dioxins that can be present in fish oil. Regulatory bodies including the FDA have granted GRAS status to algal DHA for use in infant formula, where DHA supports retinal photoreceptor development and myelination of the central nervous system during critical early growth windows. Its neutral flavor profile compared to fish oil also makes it more suitable for incorporation into formula without affecting palatability.

### How is algal DHA from Schizochytrium sp. produced, and does production method affect quality?

Algal DHA from Schizochytrium sp. is produced through fermentation of marine microalgae in controlled bioreactors, which allows for high DHA yields without ocean harvesting. The production process is well-researched for efficiency and consistency, ensuring standardized DHA concentrations across batches. Quality is primarily determined by fermentation conditions and downstream purification rather than source variability, making it a reliable and consistent ingredient for supplements.

### What makes Schizochytrium sp. algae a better sustainable source of DHA than fish oil?

Schizochytrium sp. requires no fish harvesting, reducing pressure on ocean ecosystems and eliminating concerns about overfishing and marine biodiversity loss. The microalgae can be cultivated in closed bioreactor systems using minimal water and land compared to fish farming, making it a more environmentally sustainable production method. This makes it particularly appealing for environmentally conscious consumers seeking DHA without contributing to ocean depletion.

### Is there a difference between algal DHA from Schizochytrium sp. and DHA from other algae species?

Schizochytrium sp. is specifically valued for its exceptionally high natural DHA content, making it one of the most efficient algae sources for DHA production compared to other microalgal species. While other algae like Nannochloropsis or Phaeodactylum also produce DHA, Schizochytrium sp. requires less processing to achieve therapeutic DHA levels in supplements. The species choice reflects commercial efficiency in fermentation rather than demonstrated differences in human health outcomes, as no comparative clinical studies exist.

---

*Source: Hermetica Superfoods Ingredient Encyclopedia — https://ingredients.hermeticasuperfoods.com*
*License: CC BY-NC-SA 4.0 — Attribution required. Commercial use: admin@hermeticasuperfoods.com*